Bioabsorbable Scaffolds - US Analysis and

Market Forecasts Now Available at iData

Insights
Bioabsorbable Scaffolds - US Analysis and Market Forecasts Summary Coronary artery disease (CAD) and
peripheral artery disease (PAD) are global public health and socioeconomic issues that affect millions of lives each
year. Bioabsorbable scaffolds (BAS), which provide transient support to the vessel, are viable alternatives to
permanent drug-eluting stents (DES) and bare metal stents (BMS) implants. In the report, BAS are defined as fullybioabsorbable devices that are used in stenting procedures that completely disappear from the target vessel
overtime. Stents such as BioMatrix Flex by Biosensors International and Synergy by Boston Scientific Corporation
are not included in the report because they are metallic DES with bioabsorbable polymer coatings. Absorption of
the bioabsorbable polymer coating still leaves behind a permanent BMS inside the vessel. This report focuses on
the future US Market, as BASs are currently unavailable. This report identifies the unmet needs in the market,
provides an understanding of physician perception of BAS, and evaluates the adoption of BAS in the future. Largescale, long-term studies need to be conducted to demonstrate their clinical efficacy, and once approved new stent
technologies need to be integrated appropriately into the existing reimbursement systems within the US before
widespread adoption will be seen. To successfully market BAS, companies need to design novel scaffold platforms
that address the current unmet needs of conventional drug-eluting and BMS, and show superior clinical
performance to the stents that are currently marketed and being used in modern clinics. *This is an on-demand
report and will be delivered within 4 working days (excluding weekends) of the purchase. Highlights Key Questions
Answered - What is the current and future market outlook for Bioabsorbable Scaffolds in the US region? What
trends are affecting the Bioabsorbable Scaffold market? - What are the market sizes of each bioabsorbable scaffold
segment? - What clinical factors and technical specifications will influence a physician to use bioabsorbable
scaffolds over conventional DES and BMS stents? - What are unmet needs in the bioabsorbable scaffold market?
What are the clinical and non-clinical barriers in this space? Reasons to buy - What Physicians Think quotes
provide a unique insight into how healthcare professionals are reacting to events within the industry, and what
their responses could mean for industry strategists. In this report you will understand the perceptions of leading
physicians and other stakeholders from around the world. This information is essential for all strategic decision
makers in every organization allowing them to act on high quality information.

Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=101902/bioabsorbable-scaffolds-us-analysis-and-market-forecasts

To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=101902/bioabsorbable-scaffolds-us-analysis-and-market-forecasts

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Key Metrics in the 10 Major Markets
2.2 Technological Trends
2.3 Key Players in the Bioabsorbable Scaffold Market
2.4 Bioabsorbable Scaffold Market Outlook
2.5 What Do Physicians Think?
3 Introduction
3.1 Catalyst
3.2 Related Reports
4 Disease Overview
4.1 Coronary Artery Disease
4.2 Peripheral Artery Disease

4.3 Anatomy and Physiology

4.4 Pathophysiology
4.4.1 Coronary Artery Disease
4.4.2 Peripheral Artery Disease
4.5 Clinical Presentation
4.5.1 Symptoms of Coronary Artery Disease
4.5.2 Symptoms of Peripheral Artery Disease
4.6 Risk Factors
4.6.1 Coronary Artery Disease
4.6.2 Peripheral Artery Disease
4.7 Disease Segments
4.7.1 Coronary Artery Disease
4.7.2 Peripheral Artery Disease
4.8 Diagnosis
4.8.1 Coronary Artery Disease
4.8.2 Peripheral Artery Disease
4.9 Clinical Outcomes
4.9.1 Treatment Paradigm
4.9.2 Treatment Modalities
4.9.3 Coronary/Peripheral Artery Bypass Grafting
4.9.4 Interventional Cardiology
5 Competitive Assessment
5.1 Overview
5.2 Absorb BVS - Abbott Vascular
5.2.1 Efficacy
5.3 Remedy - Kyoto Medical Planning
5.3.1 Efficacy
5.4 DESolve - Elixir Medical Corperation
5.4.1 Efficacy
5.5 Pure - Arterial Remodeling Technologies
5.5.1 Efficacy
6 Unmet Needs
6.1 Develop a Fully-Bioabsorbable Stent
6.2 Reduce the Risk of Complications
6.3 Reduce the Need for Stent-in-Stent Procedures
6.4 Long-Term Clinical Data
6.5 Reduce the Rate of Stent Fracture
6.6 Dual Anti-Platelet Therapy
6.7 Imaging
7 Pipeline Products
7.1 Overview
7.2 Coronary Artery Disease - Pipeline Products
7.2.1 Overview
7.2.2 Polymer-Based Bioabsorbable Scaffolds
7.2.3 Metallic Bioabsorbable Scaffolds
7.2.4 Summary
7.3 Peripheral Artery Disease - Peripheral Bioabsorbable Scaffold Product Pipeline
7.3.1 Overview
7.3.2 Summary
8 Industry Overview
8.1 Procedure Trends
8.1.1 Coronary Artery Disease
8.1.2 Peripheral Artery Disease
9 Market Access
9.1 Overview
9.2 Regulatory Process
9.2.1 United States
9.3 Physician Decision-Making Process
9.4 Role of Group Purchasing Organizations

9.5 Lack of Clinical Data

9.6 Regional-Level Control
9.7 Cost Considerations
9.7.1 United States
9.8 Reimbursement Trends
9.8.1 United States
9.9 Regulatory Issues/Recalls
9.10 Product Recalls
10 Mergers and Acquisitions
10.1 ART and Terumo Corparation
10.2 Xenogenics Corporation and Multicell Technologies
10.3 Icon Interventional Systems and Ariad Pharmaceuticals
10.4 Boston Scientific Corporation
11 Current and Future Players
11.1 Overview
11.2 Trends in Corporate Strategy
11.3 Company Profiles
11.3.1 Abbott Vascular
11.3.2 Kyoto Medical Planning Co., Ltd.
11.3.3 Arterial Remodeling Technologies
11.3.4 Elixir Medical Corporation
11.3.5 Cardionovum
11.3.6 Reva Medical
11.3.7 OrbusNeich Medical
11.3.8 Amaranth Medical
11.3.9 Biotronik
11.3.10 Lepu Medical Technology
11.3.11 HuaAn Biotechnology Co., Ltd.
11.3.12 Lifetech Scientific (Shenzhen) Co., LTD. (Lifetech Shenzhen)
11.3.13 Arterius
11.3.14 S3V Vascular Technologies
11.3.15 Tepha Inc.
11.3.16 Zorion Medical
11.3.17 Xenogenics Corporation
11.3.18 Meril Life Sciences
11.3.19 Boston Scientific Corporation
11.3.20 Icon Interventional Systems
12 Market Drivers, Opportunities and Barriers
12.1 Market Drivers
12.1.1 Rising Prevalence of Disease
12.1.2 Avoid Stent-in-Stent Procedures
12.1.3 Reduce/Eliminate Dual Anti-Platelet Therapy
12.1.4 Availability of Long-Term Data
12.1.5 Treatment Considerations
12.1.6 Accurate Stent Placement
12.1.7 Expected Launch of BAS in the US
12.2 Opportunities
12.2.1 BAS Segmentation
12.2.2 Expanding the Indications for BAS
12.2.3 Target High-Risk Patients
12.2.4 Improve Deliverability of BAS
12.2.5 Emerging Markets
12.3 Market Barriers
12.3.1 Slow Adoption
12.3.2 Complications Associated with BAS
12.3.3 High Average Selling Price
12.3.4 Reimbursement
12.3.5 Substitutes
13 Market Outlook and Forecast

13.1 United States

13.1.1 Overview
13.1.2 Market Analysis
14 Appendix
14.1 Bibliography
14.2 Abbreviations
14.3 Report Methodology
14.3.1 Overview
14.3.2 Coverage
14.3.3 Primary Research -Key Opinion Leader Interviews
14.3.4 Primary Research Interviews - Physician and Industry Participants
14.3.5 Physician Survey
14.3.6 Expert Panel Validation
14.3.7 Secondary Research
14.4 Forecasting Methodology
14.5 Physicians and Specialists Included in This Study
14.6 About the Authors
14.6.1 Analysts
14.6.2 James Coutcher, Global Head of Healthcare
14.7 About GlobalData
14.8 Contact Us
14.9 Disclaimer

Read More @ http://www.idatainsights.com/reports-landing-page.php?id=101902/bioabsorbable-scaffolds-usanalysis-and-market-forecasts

About Us:
iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research
information aggregator and marketing research consulting firm. We conduct both primary and secondary
research. Our work does not end with research it is also involved in distributing reports for different companies .
We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is
our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the
implementation of changes that will make a difference to their bottom line.
Contact US:
iData Insights
Tel: 1- 866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com

About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to
provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on
our promise to provide results that are essential to the success of your company. We believe that by doing so, we
will earn the trust of our clients for future projects.